Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions
- PMID: 32311761
- DOI: 10.1111/nan.12622
Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions
Abstract
Aim: To describe four novel primary epithelial tumours of the sella with papillary architecture and Thyroid Transcription Factor 1 (TTF-1) expression.
Methods: Paraffin-embedded tissue from the four cases and recurrence of patient 1 was investigated with haematoxylin-eosin, special histochemical stains, immunohistochemistry with a broad panel of antibodies and next-generation sequencing. The ultrastructure of one tumour was studied in tissue retrieved from paraffin.
Results: The lesions occurred in three females aged 20, 26 and 42 years and a male aged 49 years. They presented with signs and symptoms secondary to pituitary stalk compression. Preoperative neuroimaging documented mixed solid and cystic, enhancing sellar masses with suprasellar extension. Histologically, the tumours showed thin papillae lined by a single layer of cytokeratin and TTF-1-positive cuboidal and cylindrical cells with mildly atypical nucleus. Next-generation sequencing performed in three cases did not identify any mutations. The main differential diagnosis included metastasis from lung or thyroid carcinoma, extraventricular choroid plexus papilloma and sellar ependymoma.
Conclusion: We suggest the descriptive term of primary papillary epithelial tumour of the sella (PPETS) for this entity and propose that it could represent the intracranial equivalent of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma. The cell of origin of PPETS remains undetermined although the intense and ubiquitous expression of TTF-1 may suggest a derivation from the infundibulum or ventricular recess. Our study expands the spectrum of sellar TTF-1-positive tumour and challenges the view that they all derive from pituicytes.
Keywords: TTF-1; papillary tumour; pituitary gland; sella.
© 2020 The Authors. Neuropathology and Applied Neurobiologypublished by John Wiley & Sons Ltd on behalf of British Neuropathological Society.
Similar articles
-
Primary papillary epithelial tumor of the sella: a case report of an emerging tumor type.Brain Tumor Pathol. 2024 Jan;41(1):30-34. doi: 10.1007/s10014-023-00472-7. Epub 2023 Dec 13. Brain Tumor Pathol. 2024. PMID: 38091172
-
Primary papillary epithelial tumor of the sella and posterior pituitary tumor show similar (epi)genetic features and constitute a single neuro-oncological entity.Neuro Oncol. 2023 Aug 3;25(8):1487-1497. doi: 10.1093/neuonc/noad067. Neuro Oncol. 2023. PMID: 37058118 Free PMC article.
-
The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma.Neuropathology. 2016 Oct;36(5):432-440. doi: 10.1111/neup.12291. Epub 2016 Feb 26. Neuropathology. 2016. PMID: 26919073
-
Primary thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report and literature review.Medicine (Baltimore). 2017 Nov;96(47):e8851. doi: 10.1097/MD.0000000000008851. Medicine (Baltimore). 2017. PMID: 29381996 Free PMC article. Review.
-
Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review.Pathol Res Pract. 2014 Dec;210(12):1142-5. doi: 10.1016/j.prp.2014.04.020. Epub 2014 May 9. Pathol Res Pract. 2014. PMID: 24893893 Review.
Cited by
-
Primary papillary epithelial tumor of the sella: a case report of an emerging tumor type.Brain Tumor Pathol. 2024 Jan;41(1):30-34. doi: 10.1007/s10014-023-00472-7. Epub 2023 Dec 13. Brain Tumor Pathol. 2024. PMID: 38091172
-
Primary papillary epithelial tumor of the sella and posterior pituitary tumor show similar (epi)genetic features and constitute a single neuro-oncological entity.Neuro Oncol. 2023 Aug 3;25(8):1487-1497. doi: 10.1093/neuonc/noad067. Neuro Oncol. 2023. PMID: 37058118 Free PMC article.
-
Spindle cell oncocytoma of the pituitary tumor: A rare case report and literature reviews.Front Surg. 2023 Jan 30;9:1021680. doi: 10.3389/fsurg.2022.1021680. eCollection 2022. Front Surg. 2023. PMID: 36793516 Free PMC article.
-
DNA methylation profiling and histologic analysis of sellar TTF-1-positive papillary epithelial tumor supports a novel CNS entity.J Neuropathol Exp Neurol. 2022 Dec 19;82(1):96-98. doi: 10.1093/jnen/nlac105. J Neuropathol Exp Neurol. 2022. PMID: 36367825 Free PMC article. No abstract available.
-
Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor.Acta Neurochir (Wien). 2022 Mar;164(3):737-742. doi: 10.1007/s00701-022-05109-w. Epub 2022 Jan 14. Acta Neurochir (Wien). 2022. PMID: 35029761
References
-
- Lopes MBS. The 2017 World Health Organization classification of tumours of the pituitary gland: a summary. Acta Neuropathol 2017; 134: 521-35
-
- Kleinschmidt-DeMasters BK, Lopes MB, Prayson RA. An algorithmic approach to sellar region masses. Arch Pathol Lab Med 2015; 139: 356-72
-
- Petrakakis I, Pirayesh A, Krauss JK, Raab P, Hartmann C, Nakamura M. The sellar and suprasellar region: a "hideaway" of rare lesions. Clinical aspects, imaging findings, surgical outcome and comparative analysis. Clin NeurolNeurosurg. 2016; 149: 154-165
-
- Roncaroli F, Villa C, Chatterjee D, Mansour M, Faustini-Fustini M, Giannini C, Gnanalingham K. Rare primary non-neuroendocrine tumours of the sella. Diagn Histopathol 2019; 25: 8-15
-
- Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996; 10: 60-9
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
